The challenge of chloroquine-resistant malaria in sub-Saharan Africa

Health Policy and Planning

Volumn 16, Issue 1, 2001, Pages 1-12

  Nuwaha, F ^a  

^a MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE;

AFRICA; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DRUG EFFICACY; EPIDEMIC; HUMAN; INFECTION CONTROL; MALARIA FALCIPARUM; MEDICAL DECISION MAKING; MORTALITY; REVIEW; WORLD HEALTH ORGANIZATION;

EID: 0035111261     PISSN: 02681080     EISSN: None     Source Type: Journal    
DOI: 10.1093/heapol/16.1.1     Document Type: Review

References (127)

1. Vector control for malaria and other mosquito-borne diseases
2. Treatment of malaria outside the formal health services
3. Did medicated salt hasten the spread of chloroquine resistance in P. falciparum?
4. The dynamics of drug resistance in Plasmodium falciparum
5. Chloroquine in Africa: Critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in Sub-Saharan Africa
6. Malaria disaster in Africa
7. Malaria and Health in Africa: The present situation and epidemiological trends
8. Beyond chloroquine: Implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa
9. WHA resolution 223.12
10. Impact on mortality and fertility of a community based malaria control programme in Saradidi, Kenya
11. Comparison of two strategies for control of malaria within in a primary health care programme in the Gambia
12. Failure to participate in a malaria chemosuppression programme: North Mara, Tanzania
13. The problem of malaria and malaria control in pregnancy in sub-Saharan Africa
14. Chemoprophylaxis of malaria in Africa: The spent 'magic bullet'
15. Chloroquine chemoprophylaxis in children during peak transmission period in Ethiopia
16. Economic aspects of the use of impregnated mosquito nets for malaria control
17. The effect of delivery mechanisms on the uptake of bed net re-impregnation in Kilifi District, Kenya
18. Evaluation of fenitrothion for the control of malaria
19. Malaria vaccines - Now and the future
20. History of malaria from pre history to eradication
21. Observations on two Plasmodium falciparum infections with abnormal response to chloroquine
22. Chloroquine resistance in Thailand
23. Chloroquine resistant malaria in Kenya
24. Chloroquine resistance Plasmodium falciparum from East Africa
25. Chloroquine resistant falciparum malaria in Madagascar and Kenya
26. Incipient resistance of Plasmodium falciparum to chloroquine among a semi-immune population of the United Republic of Tanzania. Results of in vivo and in vitro studies and of an opthlamological survey
27. Chloroquine resistant falciparum malaria in semi-immune native African Tanzanians
28. Chloroquine and sulfadoxine/pyrimethamine sensitivity in Burkina Faso
29. Comparison of in vivo and in vitro tests of resistance in patients treated with chloroquine in Yaounde, Cameroon
30. Response of childhood malaria to chloroquine and Fansidar in an area of intermediate chloroquine resistance in Côte d'Ivore
31. Failure of chloroquine treatment in the highlands of Ethiopia
32. A randomized trial of chloroquine, amodiaquine and pyrimethamine/sulfadoxine in Gambia children with uncomplicated malaria
33. Follow-up of the susceptibility of Plasmodium falciparum to antimalarials in Gabon
34. Resistance of Plasmodium falciparum to antimalarial drugs in Equatorial Guinea
35. Comparative efficacy of halofantrine, chloroquine and sulfadoxine-pyrimethamine for treatment of acute uncomplicated falciparum malaria in Nigerian children
36. Isolated malaria outbreak in Somalia: Role of chloroquine-resistant Plasmodium falciparum demonstrated in Balcad epidemic
37. Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzania children aged 1-5 years
38. A systematic approach to the development of a rational malaria treatment policy in Zambia
39. Chloroquine resistant falciparum malaria in Mutare District, eastern Zimbabwe
40. Sensitivity of Plasmodium falciparum in vivo to Chloroquine and pyrimethamine-sulfadoxine in Rwanda patients in a refugee camp in Zaire
41. Impact of Chloroquine resistance on malaria mortality
42. Epidemiology of drug resistance in malaria
43. Childhood mortality during and after hospitalisation in western Kenya: Effect of malaria treatment regimens
44. Plasmodium falciparum associated anemia at a large urban hospital in Zaire
45. Challenges facing antimalarial treatment in Africa
46. Re-emergence of epidemic malaria in the highlands of western Kenya
47. An Epidemic of Plasmodium falciparum in Balcad Somalia and its causation
48. Chloroquine treatment for uncomplicated childhood malaria in an area with drug resistance: Early treatment failure aggravates anaemia
49. 1998, Interventions to improve the use of antimalarials in south-east Asia: An overview
50. The role of drug delivery systems in health care: The case of self-medication
51. Use of antimalarials drugs in Mali: Policy versus reality
52. Home treatment of febrile children with antimalarials in Togo
53. Mortality and morbidity from malaria among children in a rural area of the Gambia, West Africa
54. Hospital-based surveillance of malaria related paediatric morbidity and mortality in Kinshasa, Zaire
55. Clinical features and prognostic indicators in paediatric cerebral malaria: A study of 131 comatose Malawian children
56. 'Pseudo resistant' malaria in tropical countries
57. A community perspective on the efficacy of malaria treatment options for children in Lundazi district, Zambia
58. Seasonal variation in the perceived risk of malaria: Implications for the promotion of insecticide-impregnated bed nets
59. Guidelines for the diagnosis and treatment of malaria in Africa
60. Chloroquine resistant malaria in Africa: The challenge to health services
61. Clinical algorithm for treatment of Plasmodium falciparum malaria in children
62. Drug-resistant malaria-changing patterns mean difficult decisions
63. Cost-saving through microscopy-based versus presumptive diagnosis of malaria in adult outpatients in Malawi
64. Does the availability of blood slide microscopy for malaria at health centres improve the management of persons with fever in Zambia?
65. ParaSight®-F test compared with the polymerase chain reaction and microscopy for the diagnosis of Plasmodium falciparum malaria in travellers
66. The rapid manual ParaSight®-F test. A new diagnostic tool for Plasmodium falciparum
67. The diagnosis of Plasmodium falciparum infection using a new antigen detection system
68. Dipstick antigen capture assay for malaria detection
69. ParaSight®-F rapid manual diagnostic test of Plasmodium falciparum infection
70. Practical chemotherapy of malaria, Report a WHO scientific group
71. Systematic review of amodiaquine treatment in uncomplicated malaria
72. Serial studies on the evolution of chloroquine resistance in an area of East Africa: Findings from 1979 up to 1986
73. Comparative efficacy of chloroquine and amodiaquine in Plasmodium falciparum in Starin of north-east India
74. Chloroquine versus amodiaquine in the treatment of Plasmodium falciparum in north east India
75. Can Amodiaquine be resurrected?
76. Amodiaquine
77. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria
78. Treatment of chloroquine-resistant malaria in Africa children: A cost-effective analysis
79. Malaria: Living with drug resistance
80. Economics and its contribution to the fight against malaria
81. Pyronaridine: A promising drug for Africa
82. Self-treatment of malaria in a rural area of western Kenya
83. Rolling back malaria
84. Plants as a source of antimalarial drugs
85. A bioassay for derivative of qinghaosu (artemisinin)
86. Antimalarial plants used by Hausa in northern Nigeria
87. Herbal treatment of malaria-four case reports from the Rukararwe Partnership Workshop for Rural Development (Uganda)
88. Malaria and antimalarial plants in Roraima, Brazil
89. Herbal remedies for malaria
90. In vitro antimalarial activity of vegetal extracts used in West African traditional medicine
91. Anti-malarial activity of Nigerian Neem leaves
92. Anti-inflammatory and anti-pyretic activities of Azadirachta indica
93. Isolation and characterisation of an antimalarial agent of the Neem tree Azadirachta indica
94. Survey of plants for antimalarial activity
95. Medicinal plants in therapy
96. The present status of knowledge of the plants used in traditional medicine in western Africa. A medicinal approach and a chemical evaluation
97. Biochemical mechanism of the antimalarial activity Azadirachta indica extract
98. A community-based programme to provide prompt and adequate treatment of presumptive malaria in children
99. Changing home treatment of childhood fevers by training shop keepers in rural Kenya
100. Changing response to chloroquine for treatment of P. falciparum in Saradidi, Kenya, from 1981 to 1984
101. Serial studies on the evolution of chloroquine resistance in an area of East Africa receiving intermittent malaria chemo-suppression
102. Effect of a malaria suppression program on the incidence of Burkitt's lymphoma
103. Epidemiology of emergence and spread of drug resistant falciparum malaria in south-east Asia and Australia
104. Epidemiology of emergence and spread of drug resistant falciparum malaria in South-east Asia
105. Influence of blister packaging on the efficacy of artesunate + mefloquine over artesunate alone in community-based treatment of non severe falciparum malaria in Myanmar
106. The effectiveness of insecticide impregnated bed nets in reducing cases of malaria infection: A meta analysis of published results
107. The impact of the interventions on mortality and morbidity from malaria
108. Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bed net programme
109. Impact of permerthrin impregnated bed nets on child mortality in Kassena-Nankana district, Ghana: A randomized controlled trial
110. Insecticide-treated bednets reduce mortality and severe morbidity from malaria among children on the Kenyan Coast
111. Should governments subsidise the use of insecticide-impregnated bed nets in Africa? Implications and cost-effective analysis
112. The Gambian National Impregnated Bednet Programme: Costs, consequences and net cost-effectiveness
113. Will reducing P. falciparum transmission alter malaria mortality among African Children?
114. Combating malaria morbidity and mortality by reducing transmission
115. Comparison of the cost-effectiveness of vaccines and insecticide impregnation of mosquito nets for the prevention of malaria
116. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria
117. Duration of protection and age-dependence of the effects of the SPf66 malaria vaccine in African children exposed to intense seasonal transmission of Plasmodium falciparum
118. Efficacy trial of malaria vaccine SPf66 in Gambian infants
119. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania